From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis.
Lincecum
John M
JM
ALS Therapy Development Institute, Cambridge, Massachusetts, USA.
Vieira
Fernando G
FG
Wang
Monica Z
MZ
Thompson
Kenneth
K
De Zutter
Gerald S
GS
Kidd
Joshua
J
Moreno
Andrew
A
Sanchez
Ricardo
R
Carrion
Isarelis J
IJ
Levine
Beth A
BA
Al-Nakhala
Bashar M
BM
Sullivan
Shawn M
SM
Gill
Alan
A
Perrin
Steven
S